Showing results (1-10 of 228) with videos related to
Sort By:
Pageof 23
Cancer Management and Research|November 25, 2020
Association Between RBC Antigen Allo-Antibodies and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Treatment for Advanced CancersNatasha A Jain, Songzhu Zhao, Lai Wei, et al.Clinical Lung Cancer|January 8, 2021
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele FrequencyJean G Bustamante Alvarez, Sarah Janse, Dwight H Owen, et al.Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancerDwight H Owen, Terence M Williams, Erin M Bertino, et al.Clinical Lung Cancer|September 11, 2018
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung CancerDwight H Owen, Lai Wei, Erin M Bertino, et al.Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cellsWei-Guo Zhu, Gregory A OttersonDrugs in Context|July 2, 2019
Immunotherapy in inoperable stage III non-small cell lung cancer: a reviewNatasha A Jain, Gregory A OttersonClinical Lung Cancer|July 7, 2016
Incorporation of Antiangiogenic Therapy Into the Non-Small-Cell Lung Cancer ParadigmBenjamin F Chu, Gregory A OttersonExpert Opinion on Investigational Drugs|June 25, 2011
Romidepsin: a novel histone deacetylase inhibitor for cancerErin M Bertino, Gregory A OttersonLung Cancer (Amsterdam, Netherlands)|October 5, 2010
Benefits and limitations of antiangiogenic agents in patients with non-small cell lung cancerErin M Bertino, Gregory A OttersonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Neuroendocrine and Rare Tumor Advances: A New and Promising TRAIL EmergesDwight H Owen, Nikolaos A TrikalinosPageof 23